Human Subject Topics A - Z Index
Preface
The IRB-HSR A-Z Index is a resource for University of Virginia researchers, UVA IRB-HSR staff and UVA IRB-HSR members involved in the conduct of human subject research. The information found in the index is based on the,UVA HRPP Standard Operating Procedures, applicable federal regulations, Virginia state statutes, and University of Virginia policies.
Introduction
In accordance with federal, state and local regulations and institutional policies an IRB must review all research regardless of sponsorship, involving human subjects prior to initiation of the project in order to ensure the rights and welfare of the subjects. This is applicable to all human subject research regardless of sponsorship and performed by UVA faculty, staff or students as an agent of the University. This includes advertising, recruitment and/or screening of potential subjects.
A
Abused Subjects- see Participants in Harmful Situations: Abuse, Suicide and Threat of Harm- PI Responsibilities
- Advertising for research subjects
- Advertising Templates
- Advertising AG 3-9
Age of Majority
Agent of UVA- see UVA Agent
Aids/HIV (Subjects with..) Vulnerable Populations
Appeal of IRB Determinations- seeRebuttal or Appeal of IRB Decisions
C
Cancer Center Protocol and Review Committee (PRC)
Capacity to Consent Determination- SOM Form
Learning Shot: Clinical Researcher’s Role and Responsibility
Center for Biomedical Ethics & Humanities
Certificates of Confidentiality
Changing Status of Protocol - See Modifications
Children- See Vulnerable Populations Children
Clinical Data Repository (CDR)
- Closure Form for Grants
- Closure Form for Protocols
- Closing a Protocol- Managing Protocol After Initial Approval
- Closure AG 3-6
Cognitively Impaired Persons
- SOM Form: Determination of Capacity to Consent
- Surrogate Consent/Use of Legally Authorized Representative (LAR)
Compensation for Subjects- Research Participant Compensation Procedure
Concerns, Comments, Complaints- Research Concerns, Reporting Research Concerns or Questions
Confidentiality and Privacy- Privacy and Confidentiality
Conflict of Interest
- Conflict of Interest Committee Website
- Conflict of Interest- IRB Review Website
- Conflict of Interest- PI Responsibilities
- IRB Member or Consultant Conflict of Interest AG 1-6
- HRPP SOP Sections:
- Conflict of Interest in Research: HRPP SOP Section 21: Conflict of Interest in Research
- Investigator Conflicts of Interest HRPP SOP Section 7.5.6
- Institutional conflicts of Interest HRPP SOP Section 7.5.8
Consent
- HRPP SOP Section 11: Obtaining Informed Consent from Research Subjects and SOP Addendum Section 8.
- Capacity to Consent Determination
- Consent Addendum: Age of Majority
- Age of Majority Consent Addendum and Cover Letter
- Consent Addendum: Adult or Minor
- Consent Addendum- Pregnant Partner see Pregnant Partner Addendum Template
- Consent Addendum: Prisoner
- Consent Observation- see AG 2-19
- Consent Observation- see Post Approval Monitoring
- Consenting Process- Examples
- Consent Form Posting
- Consent Short forms for non-English Speaking Subjects
- Consenting Subjects Who Do Not Read, Speak or Understand English
- Consenting Process
- Learning Shot : "The Informed Consent Process for Clinical Research "
- Learning Shot: Use of Electronic Informed Consent
- Continuation- Aggregate Review Form
- Continuation AG 3-5
- Consent Addendum- Pregnant Partner see Pregnant Partner Addendum Template
- Consent Observation- see Post Approval Monitoring
- Consent Short forms for non-English Speaking Subjects
- Consenting Subjects Who Do Not Read, Speak or Understand English
Copies of IRB Documents- Copy Request Form
Convened Review- see Full Board (Convened) Review
D
Data and Safety Monitoring Boards
Data Use Agreement with Instructions to PI
Data Management and Sharing Plans (NIH)
dbGaP- Use of Data From dbGaP
Deadlines- - see IRB-HSR Deadlines
Debrief Release Form- see Debriefing Script For Deception Or Incomplete Disclosure
Deception Studies
Department of Defense Funded Research
Determination of Human Subject Research
- Definition of Human Subject Research- Information on Website
- Determination of Human Subjects Research Form
Devices- see Investigational Medical Devices
Drugs and Biologics See-Investigational Drugs and Biologics
Dry Run Consent Form- see MRI Dry Run Consent Template
E
Economically Disadvantaged- See Vulnerable Populations Economically and/or Educationally Disadvantaged
- CITI Training
- In Person Education
- IRB-HSR In person Education see AG 6-3
- Learning Shots
- IRB Online Education Learning Shots see AG 6-4
- Staff Member Education- see AG 2-9
- IRB Member Education- see AG 6-1
- Investigator Education- see AG 6-2
Use of Electronic Informed Consent
Embryonic Stem Cell Research- See Human Embryonic Stem Cell Research
Emergency Use
- Expanded Access - Single Patient Emergency Use of Investigational Device
- Expanded Access - Single Patient Emergency Use of Investigational Drug or Biologics
- Emergency Use Notification AG 3-11
Employees-Vulnerable Populations
- Website-Vulnerable Populations-Employees
- Additional Protections for Students and Employees AG 3-46
Engagement in Human Subject Research
- Engagement in Human Subject Research AG 3-24
- Not Engaged in Human Subject Research
- See Levels of Review
Enrollment
- Website-Protocol Exceptions
- Protocol Deviation, Noncompliance, and Protocol Exception Reporting Form
- Protocol Deviations, Noncompliance and Protocol Exceptions AG 3-22
- Enrollment Log- see Prescreening Document / Screening Log / Enrollment Log
- Enrollment Change Modification Form
Environmental Health and Safety (EHS)
Exception from Informed Consent (EFIC)
-See Planned Emergency Research with Exception from Informed Consent
Exempt Review
- Exempt Studies AG 3-1
- Exempt Criteria
- Exempt Determinations
- Exempt review-See Levels of Review
- IRB-HSR Submission Types Table
- Exempt Research Procedures
Exiting UVA- see Leaving UVA
Expanded Access
- Emergency Use or Expanded Access Consent Investigational Drug, Biologic, Device
- Request for IRB Concurrence for a Single Patient Non-Emergency Use of an Investigational Drug/Device/Biologic
- Single Patient Treatment Follow-up
- Expanded Access to Investigational Medical Devices
- Expanded Access to Investigational Medical Devices AG 3-25
- Expanded Access to Unapproved Drugs and Biologics
- Expanded Access to unapproved Drugs and Biologics (Intermediate and Large Groups) AG 3-12
Expedited Review
- Expedited Review
- Expedited Review Criteria
- Risk Assessment Tool: Expedited vs Full Board Review
- Approval of Expedited Studies- AG 3-2
External Event
- Definition- External Event
- External Events - How to Submit
- External Events- When can the Study Team stop submitting
F
Federal Wide Assurance and IRB-HSR Registration Information see FWA Information
Fetuses- see Vulnerable Populations-Fetuses
- Risk Assessment Tool: Expedited vs Full Board Review
- Approval of New Study by Full Board- AG 3-3
G
Gene Transfer- see Human Gene Transfer Research
Genomic Submission Certification Request Form
GMEC: Graduate Medical Education Committee
Grants
GRIME Committee: Group on Research in Medical Education
Guidance- see Regulations
H
HIPAA
- Protected Health Information (HIPAA)
- Learning Shot: HIPAA Best Practices: How to follow your privacy plan
- Learning Shot: HIPAA & Waiver of Consent: Terminology
- HIPAA Authorization - Stand Alone
- HIPAA Authorization - Stand Alone: Spanish
- Data Use Agreement with Instructions to PI
- 45CFR Part 160 and 164, Standards for Privacy of Individually Identifiable Health Information; Security Standards for the Protection of Electronic Protected Health Information (HIPAA Privacy and Security Rules)
Hours- IRB-HSR Office - see IRB-HSR Hours
Human Subjects Research(Scroll down page to Humanitarian Use Device)
- Human Embryonic Stem Cell Research
- Human Gene Transfer Research
- Human Subject Research Determination
- Human Subjects Research Determination Form
Human Research Activities Performed at Other Institutions
Human Research Protection Program: Standard Operating Procedure
- Humanitarian Use Device (HUD) Information Form
- Humanitarian Use Device (HUD) Patient Information Template
- Humanitarian Use Device-Non Emergency AG 3-17
I
Improvement and Assessment of IRB Administrative Procedures
- QC of AE Reporting to IRB-HSR- AG 5-1
- QC of Expiration Dates for Active Studies AG 5-2
- Annual Review of SOPS AG 5-4
- QC of Inactive Protocols Without Closed Events AG 5-5
- Internal Administrative Assessment AG 5-6
- QC of Protocols and Grants with Incorrect or Duplicate Approval/Closure Events AG 5-7
- QC of the IRB-HSR database AG 5-8
- QC of Scanned Files AG 5-9
- IBC Verification AG 5-10
- Verification of Approval Dates AG 5-11
- PRC Registration Report AG 5-12
- Wards of the State Verification AG 5-13
- Alternative Payment Verification AG 5-14
- QC of IRB-HSR Agenda and Minutes AG 5-15
- QC of Modification Submissions AG 5-16
- QC of Read Only Access to IRB Online AG 5-17
- QC of Next Meeting Date AG 5-18
- Post-approval Monitoring AG 5-19
Improvement Project vs Research- UVA Guidance
Inspections
- Inspection of IRB-HSR by Outside Agencies- AG 2-12
Inspections by Outside Agencies
International Research
- International Research (web page)
- Center for Global Health-University Scholar Award & Pfizer Initiative in International Health Research Award Instructions and Guidelines
- Consent Form Template for International Research
- Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries
- Harvard Global Research Ethics Map
- International Compilation of Human Subject Protections
- International Issues and Codes
- International IRB's
- Learning Shot: IRB-HSR protocol submission requirements for international research
- Learning Shot: Center for Global Health and the IRB
Institutional Animal Care & Use Committee (IACUC)
Institutional Biosafety Committee (IBC)
Investigational Drugs and Biologics
Investigational Medical Devices
- Devices Studies AG 3-13
- InVitro Diagnostic Devices (IVD’s)
Investigator-Initiated Investigational New Drug Application (IND) AG 3-23
Institutional Review Board (IRB)
- IRB-HSR Calendars
- IRB-HSR Deadlines
- IRB-HSR Hours
- IRB-HSR Membership Lists
- IRB-HSR Office Information
- IRB-HSR Protocols (Search)
- IRB Online
- IRB Pro
- IRB of Record- Determining to Which UVA IRB to Submit
- IRB Required Submissions-PI Responsibilities
- IRB Review Outcomes
- IRB-HSR Staff Directory- see Staff Directory
- IRB for Social & Behavioral Sciences (IRB-SBS)
IRB Meetings
- Minutes of IRB Meeting Meetings AG 4-5
- Conduct and Agenda of IRB-HSR Meetings AG 4-4
- Verification of Research Activities Since Previous IRB Review- AG 4-6
- Reliance on a Non- UVA IRB to serve as the single IRB (sIRB) of Record
- Reliance on the IRB-HSR to serve as the Single IRB (sIRB) of Record
- Reliance Agreements- see AG 2-36
- Protocols Reviewed by Non- UVA IRB- see AG 2-37
J
K
Keeping Data/Samples for Future Research
L
Lay Terminology -
Legally Authorized Representative- see Surrogate Consent / Use of a Legally Authorized Representative (LAR)
- Use of Legally Authorized Representative (LAR) AG 3-15
- Exit Checklist
- Exit Procedures for IRB-HSR Researchers- see AG 2-28
M
Medical Records
Membership Lists- see IRB-HSR Membership Lists
Minor - see Vulnerable Populations - Children/Minor
Minorities- see Vulnerable Populations-Minorities
Minutes
- Minutes of IRB Meeting Meetings AG 4-5
- Background Information
- Process for Modifications
- Modifications AG-3-4
- QC of Modification Submissions AG 5-16
- Modification Forms:
- o Change of Status Modification Form
o Enrollment Change Modification Form
o All Personnel Changes are done via IRB PRO
o Request for Modification Form
o Study Hold by PI: Found in HRPP SOP
N
Neonates - Vulnerable Populations
New Protocol Submission Process
Non- Compliance Reporting
- Non-Compliance Reporting - PI Responsibilities
- Protocol Deviations, Noncompliance, and Protocol Exception Reporting Form
- Protocol Deviations, Noncompliance and Protocol Exceptions AG 3-22
Non-Engagement in Human Subject Research- see Engagement in Human Subject Research
Non- English Speaking Subjects - See Consenting Subjects Who Do Not Read, Speak or Understand English
Non-UVA Batch AE Submission Form
Notifications
- Notification of Federal Regulatory Agencies, Institutional Officials and Funding Agencies see AG 2-7
O
Office Information- IRB-HSR Office Information
Office Management
- IRB-HSR Office Management During a Pandemic/Emergency see AG 2-25
- IRB-HSR Naming Nomenclature- see AG 2-26
- Updating and Maintaining OHRP/FDA IRB Registration/Authorization- see AG 2-27
- Protocol Development Process- see AG 2-29
- Correcting Assurance/Approval Forms and Minutes- see AG 2-31
- Protocol Builder Administrative Process- see AG 2-32
- IRB-HSR Communication with Upper Administration- see AG 2-33
Office of Sponsored Programs (OSP)/ School of Medicine Grants and Contracts Office
P
Parental/Guardian Permission-definition
Participants in Harmful Situations: Abuse, Suicide and Threat of Harm - PI Responsibilities
Partner Offices see UVA Research Compliance Committees/ Oversight Offices
Pharmacy- see Investigational Pharmacy Requirements
Personnel Changes are done via IRB PRO
Principal Investigator (PI)
- PI Qualifications
- PI Responsibilities - see Clinical researcher's roles and responsibilities
- IRB Learning Shot on Clinical researcher's roles and responsibilities
Planned Emergency Research with Exception from Informed Consent
Planned Emergency Research with Exception from Informed Consent AG 3-36
- Post Approval Monitoring
- VPR Post Approval Monitoring Website
- Post-Approval Monitoring- AG 5-19
Post Debrief Release Form for Deception Studies
PRC- see Cancer Center Protocol and Review Committee (PRC)
Pregnant Women- see Vulnerable Populations - Pregnant Women
Pregnant Partner Addendum Template
Preparatory to Research Activities
Prescreening Document / Screening Log / Enrollment Log
Prisoner- seeVulnerable Populations
- Consent Addendum: Prisoner
- Additional Protections for Prisoners- AG 3-34
- Vulnerable Subjects - Prisoner Website
Protected Health Information (HIPAA)
Protocol
- Protocol & Consent Writing Assistance
- Guidance for answering questions in protocol templates developed by Protocol Builder
- Protocol Templates (e.g. Sponsor's protocol, Investigator Initiated Protocol Templates)
- Radiation Risk Language
- Protocol Deviation- See Protocol Deviations, Noncompliance and Protocol Exceptions
- Protocol Information Form - Humanitarian Device Exemption
- Protocol renewal - see Continuing Review
- Protocol Status- See Tracking Protocol Status
- Protocol Status Change - see Modifications
Protocol Deviations
- Protocol Deviations, Noncompliance and Protocol Exceptions
- Protocol Deviations, Noncompliance, and Protocol Exception Reporting Form
- Protocol Deviations, Noncompliance and Protocol Exceptions AG 3-22
Public Health Sciences @ the Library (PHS@Library)
Privacy and Confidentiality
- IRB-HSR Confidentiality Statement- AG 2-17
- Privacy Office: UVA
Public Data Sets
- Public Data Sets
- Public Data Set Nomination Form
- Public Data Sets AG 3-29
Q
Quality Improvement- see Improvement Project vs Research- UVA Guidance
Quality Improvement- (IRB-HSR) see Improvement and Assessment of IRB Administrative Procedures
R
Radiation Exposure
- Radiation Exposure for Research Purposes
- Radiation Safety Committee (RSC) - UVA
- Radiation Safety Standard Consent Language
Rebuttal or Appeal of IRB Decisions
Receiving Data/Specimens from Outside UVA
Record Keeping
- Recordkeeping responsibilities (general)
- Research File Maintained by Study Team- PI Responsibilities
- IRB-HSR Files: Consent, Storage, Security and Destruction- see AG 2-11
- Minutes of IRB Meeting Meetings AG 4-5
- Conduct and Agenda of IRB-HSR Meetings AG 4-4
- QC of IRB-HSR Agenda and Minutes AG 5-15
- Record Retention- PI Responsibilities
Recruitment of Study Subjects
- Recruitment: See Advertising
- Subject Selection, Recruitment and Compensation
Related/Possibly Related Event
Required Submissions- see IRB Required Submissions-PI Responsibilities
Requirements for Research Conducted at non- UVA Facilities by UVA Personnel
Research Participant Compensation Procedure
Research Performed With Other Institutions
Responsibilities: Principal Investigators
S
Serious Adverse Events (SAEs) definition
Screening Log- see Prescreening Document / Screening Log / Enrollment Log
Sending Data/ Specimens Outside of UVA
Single IRB
- Reliance on the IRB-HSR to serve as the Single IRB (sIRB) of record
- Reliance on a Non-UVA IRB to serve as the Single IRB (sIRB) of record
- Reliance Agreements- see AG 2-36
- Protocols Reviewed by Non- UVA IRB- see AG 2-37
- IRB-HSR Review and Oversight when serving as the Single IRB (sIRB) of record see AG 3-50
Students- Vulnerable Populations
Subjects-
Substudies- Definition and Submission Guidance
Suicide- See Participants in Harmful Situations: Abuse, Suicide and Threat of Harm- PI Responsibilities
Surrogate Consent / Use of a Legally Authorized Representative (LAR)
T
Templates: Protocol, Consent, Consent Addendum and Consent Short Forms
Tissue Banking- see Specimen Banking
U
Unaffiliated Investigator agreement
Use of Data/ Specimens in Future Research
UVA Partner Offices for Research
UVA Research Compliance Committees/Oversight Offices
V
Verbal Consent- Waiver of Documentation of Consent
Vice President for Research (VPR)
W